Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hong Liu
Nanjing Medical University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China
Recruiting - Guangdong Provincial People'S Hospital
Guangzhou, Guangdong, China
Recruiting - Nanjing First Hospital Nanjing Medical University
Nanjing, Jiangsu, China
Recruiting - the First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
Recruiting - Subei People'S Hospital of Jiangsu Province
Yangzhou, Jiangsu, China
Recruiting - Qilu Hospital of Shandong University
Jinan, Shandong, China
Recruiting - West China Hospital of Sichuan University
Chengdu, Sichuan, China
Recruiting - the Friendship Hospital of Yili Kazak Autonomous Prefecture
Kazak, Xinjiang, China
Recruiting - the Seventh Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
Recruiting - the First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
Recruiting - Beijing Anzhen Hospital Capital Medical University
Beijing, China
Recruiting - the First Affiliated Hospital of Guangzhou Medical University
Guangzhou, China
Recruiting - the Second Affiliated Hospital of Nanchang University
Nanchang, China
Recruiting - Shanghai East Hospital Tongji University
Shanghai, China
Recruiting - Teda International Cardiovascular Hospital
Tianjin, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jul 2022
- Primary completion
- 31 Dec 2025
- Completion
- 31 Dec 2025
- Last update posted
- 12 Dec 2024
- Registered enrollment
- 330
- Registry id
- NCT05339529
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.